Catalyst Pharmaceutics Insider Sales Surge as Angelini Merger Completes, Executives Cash Out Big Shares and RSUs in Coordinated Move
Angel Pharma’s acquisition of Catalyst spurs insider sales and confirms a merger‑related exit, giving investors a premium exit while highlighting future R&D synergy.
- CATALYST PHARMACEUTICALS INC
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
11 minutes to read

